multiple sclerosis

Pharmalot By Ed Silverman

Multiple sclerosis patients see drug value differently than payers and doctors

First Opinion By Brian C. Callaghan and Lindsey De Lott

Medicare shouldn’t pay more for drugs when others pay less

Pharmalot By Ed Silverman

Insurers pay more for multiple sclerosis drug because rebates don’t help, report says

Exclusive By Sharon Begley

Bold claim of multiple sclerosis gene discovery comes under withering attack

Health By Usha Lee McFarling

FDA weighs crackdown that could shut hundreds of stem cell clinics

Health By Leah Samuel

Architect with ALS designs a residence he can control with just blinks

In the Lab By Sharon Begley

Discovery of multiple sclerosis gene could inspire new therapies — if it’s right

Pharmalot By Ed Silverman

Biogen puzzles Wall Street with plans to spin off its hemophilia business